Tag: affordability

What’s behind health insurance premiums?

With recent discussions surrounding insurance premiums, it’s important to acknowledge an important fact: Premiums track directly with the underlying cost of care. Continue reading

Posted in: Health Care Costs

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

Taking Steps to Make Coverage Affordable

There are two things Congress can do now to support affordability in health care coverage: allow states to maintain their current small-group market and repeal the health insurance tax. Continue reading

Posted in: Issue Alert

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Hill Briefing Examines the Truth About Premiums

Influential factors that go into premiums took center stage this afternoon at a Capitol Hill briefing hosted by centrist think tank Third Way. The panelists all emphasized the fact that proposed premiums vary greatly; and therefore, it’s crucial to consider the full picture when looking at changes in premiums. Continue reading

Posted in: Cost Alert, On The Hill

Rx News Roundup: Lower Prices and More Transparency

Leading oncologists are challenging exorbitant drug prices and making headlines this week by unveiling new tools aimed at driving value in cancer care. Continue reading

Posted in: Health Care Costs

The Effort to #RepealtheHIT Makes Waves on Social Media

Nationwide, efforts to repeal the burdensome health insurance tax are growing stronger than ever. Continue reading

Posted in: Issue Alert, Uncategorized

Nearly $1 trillion in the next 5 years

Global prescription drug sales will grow 4.8 percent a year until reaching $987 billion by 2020, according to a new report from EvaluatePharma. Other findings from the report upend the concept that that research and development costs are driving high prescription drug prices. Continue reading

Posted in: Health Care Costs, Uncategorized

Loud and Clear

Consumers are sending a strong message that drugmakers should hear loud and clear — prescription drug costs are unreasonable, according to the latest Kaiser Health Tracking Poll. Continue reading

Posted in: Cost Alert

AHIP Briefing: Focus on the Price

Several stakeholders gathered in Washington, D.C., this morning for a panel discussion titled “Cost of Innovation: How the Future Drug Pipeline Will Impact Patient Access, Affordability.” Continue reading

Posted in: Health Care Costs